×
10 Burning Questions We Still Have After ‘Wicked: For Good’

10 Burning Questions We Still Have After ‘Wicked: For Good’

The highly anticipated conclusion to Universal Pictures’ adaptation of Wicked has finally hit theaters, tying together the story we thought we knew about Dorothy’s arrival in Oz. However, we don’t get to see much of the teen girl from Kansas after her house lands on top of the Wicked Witch of the East and she is sent off to see the Wizard (Jeff Goldblum) with shoes that don’t belong to her, thanks to Glinda (Ariana Grande) being petty.

Wicked: For Good shines enough on the incredible music and the powerful relationship between Elphaba (Cynthia Erivo) and Glinda to distract from how it very minimally grazes over the beats of L. Frank Baum’s literary classic and MGM’s The Wizard of Oz. Yet, by the end there were so many choices made that left more questions than answers.

We’d hoped for an inspired take by visionary director Jon M. Chu, whose first Wicked installment set up a whole new version of Oz audiences around the world have fallen in love with. While the stage musical focuses on its good and bad witches, its cinematic release centered Nessarose (Marissa Bode), Fiyero (Jonathan Bailey), and Boq (Ethan Slater) as part of the ensemble. Along with them, so many setups were left unfulfilled in ways that made us want to take a trip down the yellow brick road for a conversation with the Wizard.

Here are the searing questions that still haunt and hurt us after watching Wicked: For Good.

1. Who supports the Wicked Witch, actually?

Elphie V People Of Oz
© Universal Pictures

There’s not much explanation as to whether Elphaba’s efforts to free the animals have, at least over the years, garnered her any support in between the events of Wicked and Wicked: For Good. Oz hates her for presumably stealing the Grimmerie and helping the animals escape. But she’s also hated by the animals for helping—namely, the winged monkeys and the Cowardly Lion. Meanwhile, Glinda and Fiyero go along with finding her through the Wizard and Morrible’s narrative that she needs to be apprehended but don’t publicly stand up for their friend.

2. Why isn’t Dorothy’s story seen in Wicked?

In the stage musical, it makes sense for the Dorothy of it all to be done in shadowplay, considering it’s not a two-part story. The Broadway audience goes in knowing this is an alternate take on the events of The Wizard of Oz and doesn’t really need to be filled in. Wicked: Part One, however, builds out more of the relationships, including Elphaba’s sisterhood with Nessarose and the meaning of their mother’s shoes.

For some viewers, Wicked was their first introduction to the world of Oz, and the expansion of the story would seem to lend itself to a retelling of Dorothy’s role as a way in to all of the drama between the three witches. That, and there are a lot of Dorothy dolls and figures in playsets that made it feel like we’d get a bit more in Wicked: For Good about how a teen from Kansas is accidentally used as a pawn to kill Nessarose and then enlisted to melt Elphaba.

It’s really a disservice to a character who could have used a a reimagining through Chu’s creative lens to get a new generation of teens to relate to her. I mean, teens being used as political pawns? Evergreen. We get that she’s not a main character here, but she could have been used to solidify Elphie and Glinda’s love for one another, and not as a box to check.

3. Why was Fiyero playing dumb around Tin-Man Boq?

Wizard Of Oz
© Universal Pictures

Yes, Fiyero gets turned into the Scarecrow, who joins Dorothy on the yellow brick road with the lion cub he saved, who seems to have no recollection of him but blames Elphaba for his cowardly nature, and his college friend, who has always been obsessed with his girlfriend and now has a literal ax to grind. In Wicked: For Good, Boq tries to escape the misery of being stuck with Nessa to stop Glinda from marrying Fiyero right before the Thropp sisters make him into a monster, and his motivation is still to get to Glinda even after that. He stares really hard at her from a crowd while spouting off his grievances against Elphaba for saving his life. Meanwhile, Glinda probably still doesn’t recognize Tin-Biq or her role in his male loneliness epidemic victimization. Yet, somehow, we’re supposed to believe he meets this teen girl and suddenly wants the Wizard to give him a heart? And doesn’t Fiyero’s guard suit match the Scarecrow’s outfit? Or does Fiyero say he also hates Elphaba for turning him?

4. When do Fiyero and Elphaba hatch the plan to fake her death?

The poppy field that the Wicked Witch of the West enchants to lull Dorothy and the Lion to sleep (set up at Shiz!) could have helped fill in this blank. There was no exchange between them—other than maybe giving us a moment of Fiyero seemingly turning against her because he’s “dumb” now to fool the audience and Boq—but that we could have later seen as the instant where they quickly hatched a plan before Boq came into the picture.

5. Is Boq still stalking Glinda?

Glinda New Leader
© Universal Pictures

This one haunts me the most because even when he had a heart, he was down bad for her, and then he gets one from the Wizard. So wouldn’t he just go back to being a stalker creep, but now looking more horrifying?  Glinda, you in danger, girl. But in all seriousness: Boq not getting a resolution after getting established as a core ensemble member doesn’t work.

6. Was the Wizard ever thought of as a fraud?

After he leaves Oz upon realizing he just had his daughter killed, he basically takes his balloon back sans Dorothy as per the book. Everyone in the Emerald City is happy to see him go, but why? It’s not because they really hated him; he used them against the animals to create conflict to bolster himself, but to what end? Thanks for doing nothing, I guess.

7. Did no one clock Madam Morrible as the true bad guy besides Elphaba and Glinda?

Witches Of Oz
© Universal Pictures

Morrible puppeteering the Wizard to further her cause against the animals never made sense. It might have had she gotten a backstory as to her hate of animals, maybe being related to Doctor Dillamond for being smarter than her, and knowledge being more respected than power. That kind of framework would have explained her truly wicked need to take it out on animal kind. Also, her punishment? Too tame. She enslaved animals and killed the mayor of Munchkinland. Those monkeys had better have flown her straight to Elphie for real revenge.

8. Why does caging animals remove their ability to speak?

Besides the obvious symbolism, it’s never explained if the cages make the animals normal human-world creatures or if Morrible magicked away their voices. We see Dillamond return to Shiz at the end to teach, but there are no words or any sort of redemption of Elphaba in his class, at least!

9. How does Dorothy get home?

Elphaba gets a whole song about how “there’s no place like home,” a mantra that gets Dorothy home with the tapping of the magic witch shoes, most famously seen in The Wizard of Oz, but that is weirdly set up here with no payoff. There could have been a reprise at Nessarose’s feet, where Elphaba sees that home could never appreciate her, which would a) explain why she chooses to leave Oz with Fiyero, and b) could have been overheard by Glinda to help her come to terms with her role as the Good Witch for the people. It would have been fitting for her to use those words as the spell to affirm herself as a new leader while using it to magic the Thropp slippers to get Dorothy back to Kansas.

10. Why does Elphaba abandon the shoes and Oz?

In Wicked: For Good, Elphaba’s motivation is to stay in Oz to defend it despite it pushing her out, then it’s getting her mother’s shoes back, but after her heart-to-heart with Glinda, it all is just supposed to change. It’s so odd to see her relinquish her fight to encourage her friend to use her pretty privilege for good and find the magic within herself to do what she couldn’t because she’s green. But it’s okay because she’s got her straw prince and walks off to a distant land, which may or may not be the human world. Doesn’t matter.

Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.

Source link
#Burning #Questions #Wicked #Good

suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As">Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As

that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As">Can Ozempic Treat Alcoholism? Here’s What You Should Know

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders.

Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink.

Can Ozempic Treat Alcoholism? Here’s What You Should Know
                Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s are now better known for treating obesity. In the near future, though, these drugs could have yet another vital use as treatments for alcohol addiction and other substance use disorders. Over the past few years, a growing base of evidence has suggested that GLP-1s can tamp down people’s unhealthy urges for alcohol, cocaine, and even vices like gambling. And earlier this month, researchers in Denmark published data from the first double-blinded, randomized, and placebo-controlled trial of semaglutide for alcohol use disorder in The Lancet. Over a 26-week period, the study found that people on semaglutide consumed less alcohol than those given a placebo and experienced noticeably fewer heavy drinking days when they did drink. © siamionau pavel via Shutterstock There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

 I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

 Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders? Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

 © Mohammed_Al_Ali via Shutterstock And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely. Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month? Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

 Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way. Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering? Shah: So there are a couple of things. These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

 © Sebastien Bozon/AFP via Getty If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect. Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now? Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

 So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.      #Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
© siamionau pavel via Shutterstock

There are other similar studies underway, including in the United States. Some are testing semaglutide for other kinds of substance use disorder, like opioids. Others are testing newer drugs like tirzepatide (a dual agonist that pairs GLP-1 with the hunger-related hormone GIP).

I reached out to an outside expert, Asim Shah, a professor and executive vice chair of psychiatry and behavioral sciences at Baylor College of Medicine, to talk about the emerging science surrounding GLP-1s and addiction treatment. We discussed the leading theory behind why GLP-1s can reduce addiction, his opinion of the recent Lancet trial, and what it will take for these drugs to be widely adopted as treatments for substance use disorders. The following has been lightly edited for clarity and grammar.

Ed Cara, Gizmodo: Do we have any sort of sense yet as to how or why GLP-1s seem to be working well against substance use disorders?

Asim Shah: So the craving, or pleasure, center of the brain is related to dopamine, which is a brain neurotransmitter. Whenever you crave something and you eat it or you take it, that gives you pleasure. That is the dopamine functioning in the brain. And all of this is related to the same thing, whether it’s a craving for food, craving for smoking, craving for alcohol, any drug. That’s the neurobiological mechanism of craving and pleasure, and it’s all the same mechanism.

The obesity medication Saxenda, made with liraglutide
© Mohammed_Al_Ali via Shutterstock

And incidentally, we found out that the people who were losing weight on these GLP-1s, they often also stopped smoking cigarettes and their addiction got better with alcohol. It was an incidental finding, but it’s something people are now trying to study more closely.

Gizmodo: Speaking of studies, what do you make of the newest trial published in The Lancet this month?

Shah: So this was a 26 week study, which had about 100 patients, half and half men and women both. In our world, 100 patients is a medium sized study; a larger one might usually have 300, 400, 600 patients. So this is a medium sized study, which is decent. It’s not bad. And in my opinion, it was done pretty well, not a lot of bias in the study that I saw.

Now, of course, this is not a definitive study. And you need to follow up with these patients after the weeks of study. We call these start-up studies, and they are what we base future, longer and bigger studies on. So it’s a good base, and there are other studies on the way.

Gizmodo: Broadly speaking, what are the questions that these longer and larger studies need to try answering?

Shah: So there are a couple of things.

These are different substances that people are looking at; one is alcohol, one smoking, the other is opiates. So the next studies we should be doing is to see whether GLP-1s like semaglutide can limit more than one of these addictions. Because the mechanism is the same mechanism for all the cravings and the addictions. So can it reduce all of these or just one if somebody is taking it?

Boxes of the GLP-1 medication Ozempic
© Sebastien Bozon/AFP via Getty

If we do keep seeing an effect here, it’s also important to know how quickly this happens and whether it can be sustained after you stop using a GLP-1. That’s why we have to follow people after these sorts of trials, to see if the effect can last after they stop taking the medication or if it requires people needing to stay on the drug for the effect.

Gizmodo: These sort of studies are happening. But what should be the current takeaway for people with these addictions and their doctor? Is this something that could be used in the real world right now?

Shah: Because they’re not approved right now, the takeaway should be that if you already have a current indication to take a GLP-1 which is for diabetes or obesity, certainly take it. If you also get an added advantage of stopping your smoking or alcohol use disorder, that is well and good because we don’t have approval for these disorders currently.

So in other words, if somebody comes to us and says, “Hey, I want to start these medicines for smoking cessation or alcohol use disorder,” we may not be able to prescribe it because there’s no approval. But they can be part of a study which is going on in some centers for those disorders. And if somebody already is using them for diabetes or so, and in addition, they get a benefit for alcoholism, that’s great, too.

#Ozempic #Treat #Alcoholism #Heresaddiction,Alcoholism,GLP-1s,Ozempic,Q&As
Bartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping">Top Bartesian Discount Codes: 35% OffBartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost -3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.Save up to 35% With a Bartesian Cocktail SubscriptionStandard pods on the Bartesian come in packs of 8, for  to . But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost , so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.Save 15% (Or More) When You Purchase a Cocktail BundleI can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering 0 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.Bartesian Rewards Club: Get More for Your BuckBartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a  discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.Earn 2,500 Points and Give  When You Refer a FriendThe biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least 0 on the site. Use the friend referral page here, and your friend will get a  discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get .#Top #Bartesian #Discount #Codescoupons,shopping

trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping">Top Bartesian Discount Codes: 35% Off

Bartesian is the Keurig of cocktails. After trying several automatic cocktail makers on the market, it was the only cocktail maker I could see fitting into my normal routine. It works like any capsule-style device, but with booze. You fill the Bartesian’s glass bottles with your liquor of choice, make sure there’s water in the reservoir, plop in a cocktail capsule (these typically cost $2-3), choose your drink strength, press “mix,” and then a drink comes out. (If you’ve got kids, the Bartesian Professional version comes with a lock that will stymie curious fingers.)

Do you need a Bartesian to make cocktails? Of course you don’t. You can dump tequila into sour mix anytime and call it a margarita. But perhaps you’d like to make an espresso martini, a blackberry margarita, and also a Long Island Iced Tea? The Bartesian is a sort of shortcut to a home bar, without having to store all the mixers—and a bit of a novelty. It will be fun, and silly, and the drinks are kind of fine in a Spring Break way: strong and sweet and with sometimes fun flavors. Don’t expect sophistication. Expect a bit of a party trick, the sort of thing that makes a summer a little more fun.

You’ll, of course, want a Bartesian coupon to make that fun more accessible. Luckily, the current Bartesian discount codes are good for up to 35% off.

Save up to 35% With a Bartesian Cocktail Subscription

Standard pods on the Bartesian come in packs of 8, for $20 to $25. But if you know you plan to use the cocktail machine often—garden parties, art gallery openings, a really cool barber shop, an interesting home life, Friday afternoon margaritaville—the easiest way to save on the Bartesian pods is to sign up for a cocktail subscription. No Bartesian subscription discount codes are required. Subscription boxes always cost $20, so get the ones that’d be otherwise expensive for a 20% discount—then get additional tiered discounts of Bartesian depending on volume and frequency. If you order often or in large quatnities, this can add up to 35% off the regular price.

Save 15% (Or More) When You Purchase a Cocktail Bundle

I can’t tell you what to do. But at current discounts on Bartesian cocktail bundles and add-ons, only a sucker buys a Bartesian as a standalone item. If you flip to the Bartesian bundles page, you can find multiple bundles that offer glassware and cocktail variety packs for about the same price as the machine by itself. The Mom Bundle in particular costs less than the Bartesian Pro machine by itself, but includes 8 margarita capsules and two glasses. As of April 2026, Bartesian is also offering a Mother’s Day deal, offering $100 off the Bartesian Pro or the Bartesian Duet as long as you add a cocktail capsule pack to your order. Presumably, if you are buying the machine, you’ll want the cocktail capsules anyway.

Bartesian Rewards Club: Get More for Your Buck

Bartesian also has a loyalty program that they’re calling, alternately, the Bartesian Club, the Bartesian Rewards Club, or Bartesian Mixologist Rewards. One way or the other, it doesn’t cost anything to sign up, and you get discounts. Basically, you earn 4 to 6 points per dollar you spend, plus get additional points for referring other customers, following Bartesian on Instagram, or just having a birthday. If you get a thousand points, you can redeem them for a $10 discount. There are also exclusive members-only tiers. Rewards are bigger if you’re a big spender. Here are the three membership tiers.

Earn 2,500 Points and Give $25 When You Refer a Friend

The biggest rewards bonus comes when you refer a friend who then buys a Bartesian or otherwise spends at least $150 on the site. Use the friend referral page here, and your friend will get a $25 discount using a Bertesian referral coupon code if they buy a Bartesian after using your link. You’ll also get 2,500 points on the Bartesian Rewards Club. Which is to say, you also get $25.

#Top #Bartesian #Discount #Codescoupons,shopping

Post Comment